Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Genome sequencing of Histoplasma in Alberta

PROVIDER: PRJNA790966 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17307786_1.fastq.gz	Fastqsanger.gz
	SRR17307786_2.fastq.gz	Fastqsanger.gz
	SRR17307787_1.fastq.gz	Fastqsanger.gz
	SRR17307787_2.fastq.gz	Fastqsanger.gz
	SRR17307788_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 22

Similar Datasets

Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages

Project description:To identify signaling pathways that are induced by macrophages infected with Histoplasma capsulatum, we examined the whole genome expression profile of murine bone marrow derived macrophages infected with conidia, the natural infectious particle of Histoplasma. Conidia induced the expression of signature Type I interferon response genes. The induction of a Type I interferon response was specific to conidia, yeast cells did not trigger the response. Macrophages that lack the Type I interferon receptor, IFNAR1, were infected and compared to wild-type macrophages. The expression of some Type I IFN response genes are dependent upon Keywords: Murine bone marrow derived macrophage transcriptional response to infection with Histoplasma capsulatum conidia

2010-03-01 | GSE20022 | GEO

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Histoplasma capsulatum sequencing

| PRJNA992918 | ENA

Frequency of change determines effectiveness of microbial response strategies in sulfidic stream microbiomes

Project description:Chemostat incubations were established and inoculated with sediments collected from Canyon Creek, Calgary, Alberta, Canada. The chemostats experienced oxic-anoxic change of different frequency, High-frequency, Medium-frequency and Low-frequency. 18 samples were collected at the end of the final oxic phase and the final anoxic phase in the triplicated chemostats for metagenomic and metaproteomic analysis. 26 genomes were assembled from metagenomes. Proteomes were used to investigate translational regulation of each population associated with a genome.

2023-04-26 | PXD028583 | Pride

Histoplasma capsulatum induces a Type I interferon response that contributes to pathogenesis in mice

2010-05-06 | E-GEOD-20022 | biostudies-arrayexpress

Histoplasma capsulatum strain:G184AR

Project description:Histoplasma capsulatum G184AR Genome sequencing and assembly

| PRJNA682647 | ENA

Histoplasma capsulatum G186AR

Project description:Histoplasma capsulatum G186AR Genome sequencing and assembly

| PRJNA682644 | ENA

Histoplasma capsulatum strain:WU24

Project description:Histoplasma capsulatum WU24 Genome sequencing and assembly

| PRJNA682645 | ENA